Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Grants
  • Pricing
    • Methodology
    • Initial analysis
    • Objections
    • Final analysis
  • Public tenders
  • Pricing
  • Methodology

Methodology

Overview​

This document outlines the comprehensive methodology followed for pricing analysis. The process combines multiple AI models in a structured approach to generate robust pricing strategies, incorporating both cost-based and value-based perspectives with iterative refinement through critical analysis.

Pricing Analysis Flowchart​

Detailed Methodology​

Phase 1: Initial Analysis​

The initial analysis phase establishes the foundation for pricing strategy by examining two critical perspectives:

Cost-Based Analysis​

  1. Parallel AI Analysis
    • Gemini Pro 2.5: Performs comprehensive cost structure analysis including:
      • Direct costs (materials, labor, overhead)
      • Indirect costs (R&D amortization, regulatory compliance)
      • Operating expenses allocation
      • Margin requirements
    • ChatGPT 5 Pro: Conducts independent cost analysis focusing on:
      • Activity-based costing breakdown
      • Total cost of ownership modeling
      • Competitive cost benchmarking
      • Scalability considerations
  2. Cost-Based Synthesis
    • Claude Code Opus 4.1 synthesizes both analyses to produce:
      • Consolidated cost baseline
      • Minimum viable pricing thresholds
      • Volume-based pricing tiers
      • Cost-plus pricing recommendations

Value-Based Analysis​

  1. Parallel AI Analysis
    • Gemini Pro 2.5: Evaluates value propositions including:
      • Customer value drivers identification
      • Quantifiable benefits analysis
      • ROI calculations for target segments
      • Competitive differentiation assessment
    • ChatGPT 5 Pro: Performs independent value assessment covering:
      • Willingness-to-pay research synthesis
      • Value perception mapping
      • Market positioning analysis
      • Premium pricing justification
  2. Value-Based Synthesis
    • Claude Code Opus 4.1 integrates both analyses to determine:
      • Value-based price points
      • Customer segment pricing
      • Value communication strategy
      • Premium positioning rationale

Phase 2: Strategy Unification​

Claude Code Opus 4.1 combines the cost-based and value-based outcomes to create a unified pricing strategy that:

  • Balances cost recovery with value capture
  • Identifies optimal pricing zones
  • Defines pricing architecture (tiers, bundles, add-ons)
  • Establishes pricing governance guidelines
  • Creates implementation roadmap

This unified strategy represents the culmination of the initial analysis phase.

Phase 3: Critical Review and Objections​

Claude Code Opus 4.1 performs a critical self-review of the unified pricing strategy by:

Questioning Assumptions​

  • Challenging market size and growth projections
  • Scrutinizing competitive response predictions
  • Examining customer behavior assumptions
  • Reviewing cost stability expectations

Identifying Deficiencies​

  • Gaps in market coverage
  • Missing customer segments
  • Incomplete competitive analysis
  • Overlooked implementation challenges

Finding Inconsistencies​

  • Conflicts between cost and value justifications
  • Misalignment with corporate strategy
  • Internal contradictions in pricing logic
  • Channel conflict potential

Highlighting Unnoticed Facts​

  • Regulatory constraints not initially considered
  • Market trends previously overlooked
  • Technology disruption risks
  • Partnership or ecosystem implications

Phase 4: Final Refinement​

Claude Code Opus 4.1 incorporates all objections and critical insights to produce the final pricing strategy that:

  • Addresses all identified concerns
  • Provides contingency plans for key risks
  • Includes sensitivity analysis
  • Offers implementation guidelines with clear KPIs
  • Establishes review and adjustment mechanisms

Key Principles​

Multi-Model Approach​

Leveraging multiple AI models ensures diverse perspectives and reduces single-model bias, creating more robust and comprehensive analysis.

Iterative Refinement​

The critical review phase ensures continuous improvement and catches potential issues before implementation.

Balance of Perspectives​

Combining cost-based and value-based approaches ensures pricing strategies are both financially viable and market-competitive.

Self-Critical Analysis​

The objection generation phase provides essential quality control and risk mitigation.

Implementation Notes​

  • Each AI model operates independently during parallel analysis phases to maintain perspective diversity
  • Claude Code Opus 4.1 serves as the primary synthesizer and critic due to its advanced reasoning capabilities
  • Documentation of assumptions, data sources, and decision rationale is maintained throughout the process
  • The methodology is designed to be repeatable and auditable for compliance and continuous improvement

Conclusion​

This methodology provides a systematic, multi-perspective approach to pricing analysis that combines the strengths of multiple AI models with critical self-review to produce robust, defensible pricing strategies. The iterative nature of the process ensures that final recommendations are thoroughly vetted and account for diverse considerations and potential challenges.

Previous
Pricing
Next
Initial analysis
  • Overview
  • Pricing Analysis Flowchart
  • Detailed Methodology
    • Phase 1: Initial Analysis
      • Cost-Based Analysis
      • Value-Based Analysis
    • Phase 2: Strategy Unification
    • Phase 3: Critical Review and Objections
      • Questioning Assumptions
      • Identifying Deficiencies
      • Finding Inconsistencies
      • Highlighting Unnoticed Facts
    • Phase 4: Final Refinement
  • Key Principles
    • Multi-Model Approach
    • Iterative Refinement
    • Balance of Perspectives
    • Self-Critical Analysis
  • Implementation Notes
  • Conclusion
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)